1932

Abstract

Abstract

Many antigens recognized by autologous T lymphocytes have been identified on human melanoma. Melanoma patients usually mount a spontaneous T cell response against their tumor. But at some point, the responder T cells become ineffective, probably because of a local immunosuppressive process occurring at the tumor sites. Therapeutic vaccination of metastatic melanoma patients with these antigens is followed by tumor regressions only in a small minority of the patients. The T cell responses to the vaccines show correlation with the tumor regressions. The local immunosuppression may be the cause of the lack of vaccination effectiveness that is observed in most patients. In patients who do respond to the vaccine, the antivaccine T cells probably succeed in reversing focally this immunosuppression and trigger a broad activation of other antitumor T cells, which proceed to destroy the tumor.

Keyword(s): cancerT lymphocytevaccination
Loading

Article metrics loading...

/content/journals/10.1146/annurev.immunol.24.021605.090733
2006-04-23
2024-06-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.immunol.24.021605.090733
Loading
/content/journals/10.1146/annurev.immunol.24.021605.090733
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error